References
- 대역동의보감 (對譯東醫寶鑑) (1999) 1337. 법인문화사, 서울
- 배병철 (1999) 금석 황제 내경 소문, 제 37, 370, 성보사, 서울
- LeRoith, D. and Taylor, S.I. (2003) Diabetes mellitus a Fundamental and clinical text. In Hofinann, S. and Brownlee, M.(ed.), Biochemistry and molecular cell biology of Diabetic Complications A Unifying Mechanism, 1444, Lippincott Williams & Wilkins, Philadelphia
- Edelstein, D. and Brownlee, M. (1992) Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41: 26-29 https://doi.org/10.2337/diabetes.41.1.26
- Kowluru, R.A. (2005) Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro condition. Life Science 76: 1051-1060 https://doi.org/10.1016/j.lfs.2004.10.017
- Jang, D.S., Lee, Y.M., Kim, Y.S. and Kim, J.S. (2006) Screening of Korean Traditional Herbal Medicines with inhibitory activity on Advanced Glycation End Products (AGEs) Formation. Kor. J. Pharmacogn. 37: 48-52
- 김호철 (2001) 한약약리학, 434. 집문당, 서울
- Jeon, Y.J., Li, M.H., Lee, K.Y., Kim, J.S., You, H.J., Lee, S.K., Sohn, H.M., Choi, S.J., Koh, J.W. and Chang, I.Y. (2006) KIOM-79 inhibits LPS-induced iNOS gene expression by blocking NF-kB/Rel and p38 kinase in murine macrophages. J. of Ethnopharmacology, accepted
- Kim, J.S., Kim, H.Y. and Ko, J.H. (2002) Studies om the processing of herbal medicines (III)-HPLC Analysis of Magnolol and Inhibitory Effects on the Formation of Advanced Glycation Endproducts(AGEs) in vitro of Unprocessed and Processed Magnoliae Bark-. Kor. J. Pharmacogn. 33: 308-311
- Lee, J.Y and Kang, B.S. (1994) Processing of herb medicines and clinical application, 124. Younglim publishes Co., Seoul
- Lee, J.Y. and Kang, B.S. (1994) Processing ofherb medicines and clinical application, 136. Younglim publishes Co., Seoul. 109
- Abiko, T.A., Abiko, S., Ishiko, M., Takeda, M., Horiuchi, S. and Yoshida, A. (1999) A Relationship between autofluorescence and advanced glycation end products in diabetic lenses. Exp. Eye Res. 68: 361-366 https://doi.org/10.1006/exer.1998.0615
- Park, Y., Lee, H., Koh, C.S., Min, H., Yoo, K., Kim, Y. and Shin, Y. (1995) Prevalence of diabetes and lar in Yonchon county, South Korea. Diabetes care 18: 545-548 https://doi.org/10.2337/diacare.18.4.545
- 검호철 (2001) 한약약리학, 92. 집문당, 서울
- Kang, K.A., Chae, S., Koh, Y.S., Kim, J.S., Lee, J.H., You, H.J. and Hyun, J.W. (2005) Protective effect of puerariae radix on oxidative stress induced by hydrogen peroxide and streptozotocin. Biol. Pharm. Bull. 28: 1154-1160 https://doi.org/10.1248/bpb.28.1154
- Chen, W.C., Hayakawa, S., Yamamoto, T., Su, H.C. and Cheng, I.M. (2004) Mediation of beta-endorphin by the isoflavone puerarin to lower plasma glucose in streptozotocin- induced diabetic rats. Planta Med. 70: 113-116 https://doi.org/10.1055/s-2004-815486
- 김호철 (2001) 한약약리학, 211. 집문당, 서울
- 김호철 (2001) 한약약리학, 181. 집문당, 서울
- Alarcon-Aguilara, FJ., Roman-Ramos, R., Perez-Gutierrez, Aguilar-Contreras, A., Contreras-Weber, CC. and FloresSaenz, JL. (1998) Study of anti-hyperglycemic effect of plants used as antidiabetics. J. of Ethnopharmacology 61: 101-110 https://doi.org/10.1016/S0378-8741(98)00020-8
- Chizuko, H., Kanji, Y. and Toshihide, Y. (2004) Efficacy of bofu-tsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance. Clin. Exp. Pharmacol. Physiol. 31: 614-619 https://doi.org/10.1111/j.1440-1681.2004.04056.x
- Aida, K., Tawata, M., Shindo, H., Onaya, T., Sasaki, T., Yamaguchi, T., Chin, T. and Mitsuhashi, H. (1990) Isoliquiritigenin: a new aldose reductase inhibitor from glycyrrhizae radix. Planta Med. 56: 254-258 https://doi.org/10.1055/s-2006-960950
- 김호철 (2001) 한약약리학, 434 : 집문당, 서울
- Cooper, M.E. (2000) Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 44: 1957-1972 https://doi.org/10.1007/s001250100000
- Rumble, J.R., Cooper, M.E., Soulis, Cox, T., Wu, A.L. and Youssef, S., Jasik, M., Jerums, G. and Gibert, R.E. (1997) Vascular hypertrophy in experimental diabetes. J. Clin. Invest. 99: 1016-1027 https://doi.org/10.1172/JCI119229
- Sharma, K. and Ziyadeh, F.N. (1995) Hyperglycemia and diabetic kidney disease. The case for transforming growth factor- beta as a key mediato. Diabetes 44: 1139-1146 https://doi.org/10.2337/diabetes.44.10.1139
- Nakamura, N., Yamazaki, K., Satoh, A., Urakaza, M., Kobayashi, M., Yamabe,H., Osawa, H., Shirato, K., Sugawara, T., Nakamura, M., Tamura, M. and Okumara, K. (2003) Effects of epalrestat on plasma levels of advanced glycation end products in patients with type 2 diabetes. In Vivo 17: 177-180
- Ishii, H., Tada, H. and Isogai, S. (1998) An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-beta and protein kinase C activity in cultured mesangial cells. Diabetologia 41: 362-364 https://doi.org/10.1007/s001250050916